Dimensional Fund Advisors
OVID icon

Dimensional Fund Advisors’s Ovid Therapeutics OVID Stock Holding History

Dimensional Fund Advisors’s Portfolio OVID Stock Details OVID Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
+387,767
New +$1M ﹤0.01% 2856
2025
Q2 		– Sell
-10,719
Closed -$3.34K – 3313
2025
Q1 		$3.34K Sell
10,719
-82,252
-88% -$50.6K ﹤0.01% 3320
2024
Q4 		$86.9K Sell
92,971
-11,040
-11% -$12.4K ﹤0.01% 3253
2024
Q3 		$123K Sell
104,011
-170,971
-62% -$179K ﹤0.01% 3223
2024
Q2 		$211K Sell
274,982
-67,187
-20% -$187K ﹤0.01% 3154
2024
Q1 		$1.04M Buy
342,169
+98,874
+41% +$331K ﹤0.01% 2918
2023
Q4 		$784K Buy
243,295
+100,437
+70% +$343K ﹤0.01% 2974
2023
Q3 		$549K Buy
142,858
+20
+0% +$72 ﹤0.01% 3034
2023
Q2 		$469K Hold
142,838
– – ﹤0.01% 3075
2023
Q1 		$369K Buy
+142,838
New +$338K ﹤0.01% 3087
2022
Q3 		$77K Buy
+41,720
New +$87.3K ﹤0.01% 3364
2022
Q2 		– Sell
-19,564
Closed -$61K – 3513
2022
Q1 		$61K Hold
19,564
– – ﹤0.01% 3444
2021
Q4 		$63K Buy
+19,564
New +$67K ﹤0.01% 3471
2020
Q4 		– Sell
-52,819
Closed -$303K – 3358
2020
Q3 		$303K Hold
52,819
– – ﹤0.01% 3154
2020
Q2 		$389K Sell
52,819
-8,975
-15% -$42K ﹤0.01% 3122
2020
Q1 		$184K Sell
61,794
-28,907
-32% -$97.4K ﹤0.01% 3213
2019
Q4 		$376K Hold
90,701
– – ﹤0.01% 3178
2019
Q3 		$294K Hold
90,701
– – ﹤0.01% 3229
2019
Q2 		$168K Hold
90,701
– – ﹤0.01% 3345
2019
Q1 		$161K Buy
90,701
+3,444
+4% +$8.61K ﹤0.01% 3334
2018
Q4 		$211K Buy
87,257
+8,995
+11% +$41K ﹤0.01% 3277
2018
Q3 		$444K Buy
+78,262
New +$593K ﹤0.01% 3199

Other funds holding OVID

JT
Jupiter Topco New York $245B AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Dimensional Fund Advisors's OVID Position: Q2 2026 in Review

Dimensional Fund Advisors opened a new position in Ovid Therapeutics (OVID) in Q2 2026: 387,767 shares worth $1.04M. The stake represents ﹤0.01% of the portfolio and ranks #2856 among its holdings. This is a return to the name: Dimensional Fund Advisors previously reported a position in OVID as recently as Q1 2025.

Dimensional Fund Advisors first reported a position in OVID in Q3 2018 and has held it in 22 quarters since. The position peaked at $1.04M in Q1 2024. 130 funds tracked by Wall St. Rank hold OVID as of Q2 2026.

  • Dimensional Fund Advisors held 387,767 shares of Ovid Therapeutics worth $1.04M as of Q2 2026.
  • Ovid Therapeutics was a new Dimensional Fund Advisors position in Q2 2026.
  • Ovid Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2856 holding.
  • Dimensional Fund Advisors first reported a position in Ovid Therapeutics in Q3 2018 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's Ovid Therapeutics position peaked at $1.04M in Q1 2024.
  • 130 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.